Hamlet BioPharma AB publ (XSAT:HAMLET B) E10: kr-0.22 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:HAMLET B Hamlet BioPharma AB publ XSAT:HAMLET B
31 GF Score
Price kr6.72
! 2 Warning Signs
View Full Analysis

What is Hamlet BioPharma AB publ E10?

Hamlet BioPharma AB publ XSAT:HAMLET B +0.75% 31 E10 is kr-0.22 as of Mar. 2026. GuruFocus rates XSAT:HAMLET B with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hamlet BioPharma AB publ's adjusted earnings per share data for the three months ended in Mar. 2026 was kr-0.066. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-0.22 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-18), Hamlet BioPharma AB publ's current stock price is kr6.72. Hamlet BioPharma AB publ's E10 for the quarter that ended in Mar. 2026 was kr-0.22. Hamlet BioPharma AB publ's Shiller PE Ratio of today is .


Hamlet BioPharma AB publ  (XSAT:HAMLET B) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Hamlet BioPharma AB publ E10 Related Terms


Hamlet BioPharma AB publ E10 Historical Data

* Premium members only.

The historical data trend for Hamlet BioPharma AB publ's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hamlet BioPharma AB publ E10 Chart

Hamlet BioPharma AB publ Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.18 -0.21

Hamlet BioPharma AB publ Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.20 -0.21 -0.21 -0.22 -0.22

XSAT:HAMLET B vs VRTX, REGN, RVMD: E10 Comparison

For the Biotechnology subindustry, Hamlet BioPharma AB publ's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hamlet BioPharma AB publ Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hamlet BioPharma AB publ's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hamlet BioPharma AB publ's Shiller PE Ratio falls into.


XSAT:HAMLET B
31GF Score
Hamlet BioPharma AB publ XSAT:HAMLET B
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hamlet BioPharma AB publ E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hamlet BioPharma AB publ's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.066/133.5600*133.5600
=-0.066

Current CPI (Mar. 2026) = 133.5600.

Hamlet BioPharma AB publ Quarterly Data

per share eps CPI Adj_EPS
201606 -0.023 101.019 -0.030
201609 -0.014 101.138 -0.018
201612 -0.030 102.022 -0.039
201703 -0.072 102.022 -0.094
201706 -0.026 102.752 -0.034
201709 -0.042 103.279 -0.054
201712 -0.036 103.793 -0.046
201803 -0.055 103.962 -0.071
201806 -0.035 104.875 -0.045
201809 -0.031 105.679 -0.039
201812 -0.034 105.912 -0.043
201903 -0.041 105.886 -0.052
201906 -0.067 106.742 -0.084
201909 -0.027 107.214 -0.034
201912 -0.077 107.766 -0.095
202003 -0.059 106.563 -0.074
202006 -0.061 107.498 -0.076
202009 -0.018 107.635 -0.022
202012 -0.027 108.296 -0.033
202103 -0.022 108.360 -0.027
202106 -0.007 108.928 -0.009
202109 -0.018 110.338 -0.022
202112 -0.026 112.486 -0.031
202203 -0.038 114.825 -0.044
202206 -0.068 118.384 -0.077
202209 -0.049 122.296 -0.054
202212 -0.054 126.365 -0.057
202303 -0.048 127.042 -0.050
202306 -0.032 129.407 -0.033
202309 -0.070 130.224 -0.072
202312 -0.070 131.912 -0.071
202403 -0.098 132.205 -0.099
202406 -0.069 132.716 -0.069
202409 -0.061 132.304 -0.062
202412 -0.081 132.987 -0.081
202503 -0.070 132.825 -0.070
202506 -0.099 133.699 -0.099
202509 -0.066 133.480 -0.066
202512 -0.084 133.390 -0.084
202603 -0.066 133.560 -0.066

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of kr-0.22 mean?
Hamlet BioPharma AB publ (XSAT:HAMLET B) has a E10 of kr-0.22 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Hamlet BioPharma AB publ and its competitors.
Is Hamlet BioPharma AB publ's E10 too high?
Hamlet BioPharma AB publ's current E10 is kr-0.22. Overall, Hamlet BioPharma AB publ has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Hamlet BioPharma AB publ's E10 compare to VRTX and REGN?
Hamlet BioPharma AB publ's E10 of kr-0.22 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Hamlet BioPharma AB publ and its competitors. Hamlet BioPharma AB publ's current E10 is kr-0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hamlet BioPharma AB publ stock overvalued right now?
Hamlet BioPharma AB publ (XSAT:HAMLET B) has a current E10 of kr-0.22. The current E10 is kr-0.22. Hamlet BioPharma AB publ's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Hamlet BioPharma AB publ (XSAT:HAMLET B), the current E10 is kr-0.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hamlet BioPharma AB publ Business Description

Other Exchanges 7ZT:Germany
Address Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.
31GF Score

Get the complete analysis for XSAT:HAMLET B

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr6.72
Price